Immunovant Inc

Stock Chart, Company Information, and Scan Results

$31.18(as of Jun 10, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Immunovant Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$31.18
Ticker SymbolIMVT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees315
CountyUSA
Market Cap$6,489.8M
EBIDTA-532.5M
10-Day Moving Average31.91
P/E Ratio-12.56
20-Day Moving Average31.44
Forward P/E Ratio0.00
50-Day Moving Average28.84
Earnings per Share-2.84
200-Day Moving Average24.16
Profit Margin-Infinity%
RSI51.93
Shares Outstanding205.3M
ATR1.73
52-Week High36.29
Volume1,465,472
52-Week Low14.32
Most Recent Support Level30.24
Book Value852.6M
Most Recent Resistance Level32.89
P/B Ratio7.45
Upper Keltner35.33
P/S RatioInfinity
Lower Keltner27.54
Debt-to-Equity Ratio35.33
Next Earnings Date08/10/2026
Cash Surplus797.7M
Next Ex-Dividend DateUnknown

Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

Immunovant Inc In Our Stock Scanner

As of Jun 11, 2026
example chart graphic
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.